5. 進行性核上性麻痺 Progressive supranuclear palsy Clinical trials / Disease details

臨床試験数 : 89 / 薬物数 : 107 - (DrugBank : 40) / 標的遺伝子数 : 65 - 標的パスウェイ数 : 108

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2008-007520-26-DE (EUCTR)	24/06/2010	13/11/2009	A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to assess the Efficacy, Tolerab ...	A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to assess the Efficacy, Tolerab ...	Progressive Supranuclear Palsy MedDRA version: 12.0;Level: PT;Classification code 10036813;Term: Pro ...	Trade Name: Azilect INN or Proposed INN: Rasagilin Other descriptive name: RASAGILINE MESILATE	Klinikum der Universität München	NULL	Not Recruiting			Female: yes Male: yes		Phase 3	Germany
2	NCT01187888 (ClinicalTrials.gov)	January 2010	20/8/2010	Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy	A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety ...	Progressive Supranuclear Palsy	Drug: Rasagiline;Drug: Sugar pill	Prof. Dr. Stefan Lorenzl	Teva Pharmaceutical Industries;Ludwig-Maximilians - University of Munich	Terminated	50 Years	80 Years	Both	44	Phase 3	Germany

First Previous1Next Last